Cargando…
Menaquinone-7 Supplementation to Reduce Vascular Calcification in Patients with Coronary Artery Disease: Rationale and Study Protocol (VitaK-CAC Trial)
Coronary artery calcification (CAC) develops early in the pathogenesis of atherosclerosis and is a strong and independent predictor of cardiovascular disease (CVD). Arterial calcification is caused by an imbalance in calcification regulatory mechanisms. An important inhibitor of calcification is vit...
Autores principales: | Vossen, Liv M., Schurgers, Leon J., van Varik, Bernard J., Kietselaer, Bas L. J. H., Vermeer, Cees, Meeder, Johannes G., Rahel, Braim M., van Cauteren, Yvonne J. M., Hoffland, Ge A., Rennenberg, Roger J. M. W., Reesink, Koen D., de Leeuw, Peter W., Kroon, Abraham A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4663571/ https://www.ncbi.nlm.nih.gov/pubmed/26516910 http://dx.doi.org/10.3390/nu7115443 |
Ejemplares similares
-
Menaquinone Content of Cheese
por: Vermeer, Cees, et al.
Publicado: (2018) -
Comparison of menaquinone-4 and menaquinone-7 bioavailability in healthy women
por: Sato, Toshiro, et al.
Publicado: (2012) -
Mechanisms of arterial remodeling: lessons from genetic diseases
por: van Varik, Bernard J., et al.
Publicado: (2012) -
Yogurt drink fortified with menaquinone-7 improves vitamin K status in a healthy population
por: Knapen, Marjo H. J., et al.
Publicado: (2015) -
CAC-Covid-FMJ
por: Possari, R., et al.
Publicado: (2021)